ng-nitroarginine methyl ester has been researched along with African Sleeping Sickness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eneroth, A; Kristensson, K; Olsson, T; Wiesenfeld-Hallin, Z | 1 |
| Liew, FY; Mabbott, N; Sternberg, J; Sutherland, I | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and African Sleeping Sickness
| Article | Year |
|---|---|
A new approach for the pathogenesis of human African trypanosomiasis.
Topics: Animals; Arginine; Brain; CD8-Positive T-Lymphocytes; Disease Models, Animal; Enzyme Inhibitors; Ganglia, Sensory; Ganglia, Spinal; Growth Substances; Hot Temperature; Humans; Hyperalgesia; Injections, Spinal; Interferon-gamma; Mice; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nociceptors; Rats; Trypanosoma brucei brucei; Trypanosomiasis, African | 1994 |
Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection.
Topics: Animals; Arginine; Male; Mice; Mice, Inbred C3H; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Trypanosoma brucei brucei; Trypanosomiasis, African | 1994 |